Prof Carolyn Lam, National Heart Center, Singapore and Dr Akshay Desai, Brigham and Women’s Hospital, Boston, US, discuss guidelines, data and ongoing trials around SGLT2 inhibitors in heart failure at AHA 2019, held in Philadelphia in November 2019.  

This peer-to-peer discussion was funded by an unrestricted educational grant from Boehringer Ingelheim.

Filmed on-site by Radcliffe Cardiology.

Videography by Tom Green